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THE STATE OF PAHANG 
Evidence of habitation in Pahang dates back to the 
Mesolithic Era. Long famous for the deposits of tin and gold 
found along the upper reaches of the Tembeling River, Pahang 
had attracted the interest of outside powers long before the 
founding of Malacca in 1400. Under the control of the 
maritime empire of Srivijaya (centered around Palembang in 
southeast Sumatra), Pahang had expanded to cover the entire 
southern portion of the Malay peninsula in the eight and ninth 
centuries. 
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FIGURE 1: EAST AND WEST MALAYSIA 
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FIGURE 2: STATE OF PAHANG 
With the collapse of Srivijaya power around 1000, 
Pahang was claimed first by the Siamese and then, in the 
late fifteenth century, by Malacca. After Malacca fell to the 
Portuguese in 1511, Pahang became a key part of the 
territorial struggles between Acheh, Johor, the Portuguese, 
and the Dutch. Repeated raids, invasions, and occupations 
devastated the state, until the decline of both Achenese and 
Portuguese power in the early 17th century allowed Johor 
(the successor state to Malacca) to reestablish its influence. 
In the I ate ei ghteenth century Pahang gradually gai ned 
vm 
autonomy, and in the middle of the nineteenth century it had 
become an independent state. 
Mention Pahang to a Malaysian, and he will probably 
conjure up visions of lush tropical forests, cool mountain 
air, beaches, lakes and waterfalls nestling in the arms of 
mountain crevices. The largest state in peninsular Malaysia 
IS, In many ways, one of its most wild and Edenic. Two 
thirds of it is covered by unspoiled rain forest. 
Visitors to Pahang are usually there to visit the state's 
famous hill resorts, its internationally-known islands and 
beaches, or Taman Negara, the Peninsula's finest park. Each 
of these attractions is substantial enough to merit special 
attention in our pages. Pahang's other attractions, though 
less well-known, should not be missed by anyone visiting 
the state 
The natural heart of Pahang is unquestionably Taman 
Negara, Malaysia's oldest national park, lovingly referred to 
as "The Green Heart. It Within the park IS also the 
peninsula's highest point, the forest encrusted Gunung 
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Tahan. Also in the interior are many of Malaysia~s hill 
stations, mountain resorts where the tropical heat is kept at 
bay by the altitude. On the coast of Pahang, the jungle gives 
way to clean, palm-lined beaches, fishing villages, and the 
multicultural state capital, Kuantan. 
Pahang is the largest state in Peninsular Malaysia and is 
situated in the eastern coastal region. The state"s 35,964 sq. km 
encompasses a remarkable range of Malaysia t s many different 
environments, from the majestic peaks and cool hill regions of 
the state~s western region to the miles of soft sand beach along 
the South China Sea. Pahangts nearly one million people 
constitute a representative mix of Malaysiats three main ethnic 
communities Malay, Chinese, Indian and Orang-asli. The total 
popUlation of Malaysia in Census 2000, about 21,890 thousand 
or 94.1 % were Malaysian citizens. Of the total Malaysian 
citizens, Bumiputera comprised 65.1 %, Chinese 26.0% and 
Indians 7 _7%., the ethnic composition being 60.60/0., 28.1% and 
7.9% respectively in 1991. Non-Malaysian citizens totalled 
1,385 thousand (or 5.9%) in Census 2000 as against 805 
thousand (or 4.4%) in 1991. 
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HOSPITAL TENGKU AMPUAN AFZAN 
KUANTAN PAHANG D.Y 
Hospital Tengku Ampuan Afzan (HT AA) is the maID 
hospital for the state of Pahang which is one of the component 
states of Malaysia . The Obstetrics and gynaecology unit 
provides specialist services as and integral part of the HT AA 
complex. 
The Hospi tal consists of 900 beds and 1300 staff. It serves 
the town of Kuantan which is the capital own of the state of 
Pahang. It also serves as the referal centre for the outlying 
district hospital, out-patient clinic and the private medical 
practioners. 
The department of obstetrics and gynaecology has five 
consultant specialist, five registrar, five medical officer and a 
minimum of ten house-officer. The trainees do an averages 
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number of eight calls a month. They involve actively in the 
management of emergency cases during on call under close 
supervision of the specialist consultants. 
There are 36 bed in the antenatal \vard cases which are 
admitted to the antenatal ward will usually be assessed in the 
screening I admission room. The Obstetrics unit also provides 
day care services to patients who come for observation for 
maternal and fetal well being or blood investigations such as 
blood sugar profile. 
The Labour room has 10 beds of which 2 beds are used for 
monitoring of pre-eclampsia cases. Being a husband friendly 
ward , there are 3 beds whereby the patient's husbands or 
companion are allowed to be with the patients throughout 
process as well as during deliveries of the baby _ For the year 
1995-1999 ,there was a total number 39011 deliveries. In year 
1999 total deliveries was 8647 . The statistics are as follows: 
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Table 2: Deliveries in HTAA in a year of 1999 
Total number of deliveries 8647 
Nonna) deliveries 7057 
Breech deliveries 181 
Twins 65 
Triplet 1 
Forceps 57 
Vacurn 81 
Caesarian sections 1205 (13.9%) 
The postnatal ward has 44 beds and being a baby friendly 
hospital almost 99% of the post natal mother achieves breast 
feeding fully. the gynaecological ward has 36 beds with an 
average admission of 10 cases a day and a total 331 admission 
for the year 1999. 
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There are two operative sessIons per week for elective cases. 
The facility for caesarean sections is shared between the general 
operating theatre and the maternal operating theatre which is 
located adjacent to the labour ward. 
We perform a wide variety of the gynecological operation 
which include total abdominal hysterectomy, vaginal 
hysterectomy, wertheim hysterectomy , oophorectomy, 
cystectomy, myomectomy, laparoscopic and hysteroscopy 
procedure, sterilization, culposuspension and minor procedure 
such as evacuation of product of conception and marsupilazation 
and so on. 
The department also conduct regular teaching seSSIons 
such as the weekly registrar presentation, viva sessions, and 
journal club. We also have a regular caesarean audit and 
perinatal mortality and morbidity audit every fortnightly and a 
combined meeting with the paediatric department monthly. 
Since 1999 HT AA also become the teaching hospital for 
the medical faculty of University Islam Antarabangsa ( 
International Islamic University). With the Input of this 
university ,the hospital is expected to be even better equipped 
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with medical facilities and have more academic programmes in 
the near future. 
Table 3: THE CLINIC SCHEDULE 
DAY Morning Afternoon 
Monday Antenatal Clinic Day Postgraduate programme 
Tuesday Gyneacology clinic House Officer teaching 
session 
Wednesday Operation Day Caesarean Census I 
Perinatal Morbidity and 
Mortality Census 
Thursday Gyneacology Clinic Journal club 
Friday Operation Day HPE or Oncology 
discussion 
Saturday Grand ward round/ lUI 
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ABSTRACTS 
( Malay version) 
ABSTRAK 
OBJECTIF :Mengkaji epidemologi dan keadaan penyakit , rawatan GTD 
dan me/that corak penurunan B-hCG penyakit H.M Mengesan faktor yang 
boleh menambah risiko pembentukan GTT dan H.M..Membandingkan 
kesan rawatan yang diberi kepada GrT yang diketahui anteseden 
kandungan (H.M) dan GrT yang tidak diketahui anleseden kandungan. 
METODOLOGI: la adalah kajian Cross-Sectional ke alas 96 pesakit 
GTD di Hospital Besar Tengku Ampuan A/zan Kuantan, selama j tahun( 
Januari 1995- Disember /999). 
KEPUTUSAN: Dalam kelahiran sebanyak 39,01] da/am tempoh kajian di 
HTAA terdapat 96 kes GTD, kadar GTD di Hospital 1 :410 kelahiran. 
Kadar penyakit di/ihat lebih kerap do/am golongan minoritl: umur 41 
tahun dan ke atas , sosio-ekonomi yang rendah dan pariti lebih dari 5 . 
Gejala yang kerap dilihai ialah pendarahan haid yang tidak menentu, 
(87%). "'Snow storm n dapat di/ihat dengan ultrasound pada 74% pesakit. 
Pada pesakit Hydatidiform Mole didapati 64% mempunyai rahim 
besar dart larikh amenorhea. Ujian bersiri serum bHCG (n=71) . 79% 
XVI 
(n=56) beransur susut dengan spontan da/am tempoh 14 minggu dan 21% 
(n= J5) pesaki! mempunyai susutan yang tidak normal dan hertukar ke 
GTT~ Faktor yang dapal mengesan risiko pembentukan GTT ada/all umur 
40 lahun ke alas, pariti lebih dari 5, ranim hesar dari larikh haiti, 
bacaan awal BHCG > 100,000 miu/mi selepas evakuasi dan darah tinggi. 
Jenis HA,f, Theca lutein cyst, jenis darah tidak mempunyai risiko yang 
signifilcan. Lapan puluh lima kes dirawal dengan 'cuci" (suction and 
curretages) dan 8 kes histerektomi (termasuk 7 pesakit di 'cuc;" sebelum 
histerektomi). 62.5% dari pesakit GTT menerima regim kemoierapi risiko 
rendah. 17.4% menerima regim risiko sederhana dan 17.4% menerima 
regim risiko tinggi. Kila dapati liada hubungan yang sig111fikan di antara 
dua status antesedan kandungan da/am lconteks nisterektomi, jenis 
kemoterapi dan respon terhadap kemoterapi dan kematian. 
KESIMPULAN: GTD berlaku pada kadar 1 dalam 410 kelahiran dan 
faklor risiko untuk bertulcar lee GTT boleh dilcenal pasti. Perhatian yang 
.~erius adalh penting lantas dapat merawat dengan betuL Harapan untuk 
sembuh dari penyakit GTD adalah besar walaupun fe/ah menular ke GTT. 
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ABSTRACTS 
OBJECTIVES: To study the epidemiology, features, treatment of 
Gestational Trophoblastic Disease (GTD) and regression of serum B-
heG in Hydatidiform mole. To identify factors that predict the risk of 
developing Gestational Trophoblastic Tumour (GTT) from Hydatidiform 
mole and to compare the outcome of treatment between Gestational 
Trophoblastic Tumour (GTT) from known antecedent pregnancy 
(Hydatidiform mole) and unknown antecedent pregnancy. 
METHODOLOGY: A Cross Sectional study of 96 cases of 
Gestational Trophoblastic Disease in General Hospital of Tengku Ampuan 
Ajzan Kuantan for a period of 5 years (January 1995-December 1999). 
RESULTS: The prevalence rate of GTD in this hospital was 1 : 410 
deliveries. There were 96 cases of GTD out of 39,011 deliveries. The 
prevalence rate was higher in the minority ethnic groups, women of 
lower socio-economic status, age ~ 41 years and parity more than 5. 
The commonest presentations was irregular vaginal bleeding (87%). 
Typical snow storm appearance was seen in 74.4% of the patients. 
In patient with hydatidiform mole, 64% has uterus larger than 
dale. In patient with available serial serum B-hCG (n= 71), 79% (n=56) 
XVITI 
regressed spontaneously within 14 weeks and 21% (n=15) had abnormal 
regression and were diagnosed to have Gestational Trophoblastic Tumour 
(GTT) . The significant risk predictors for development of GTT were age 
above 40 years, parity 5 and above, uterus larger than date, initial pre-
evacuation B-hCG more than 100,000 miulml and pre-eclampsia . . Type 
of hydatidiform mole, presence and size of theca lutein cyst and blood 
group were not significant predictor ofGTT. Eighty five patients were 
treated with suction curettage only and 8 patients (including 7 patients 
that had evacuation initially) had hysterectomy. 65.2% ofGTT received 
low risk, 17.4% received moderate and 17.4% received high risk regime 
of chemotherapy. There was no significant correlation between GTT 
from known and unknown antecedent pregnancy in relation to 
hysterectomy, type of chemotherapy, response of chemotherapy and 
mortality. 
CONCLUSIONS: GTD occurred in about 1: 410 deliveries and risk 
factors for development ofGTT had been identified. Close monitoring of 
GTD was mandatory so that appropriate management could be given. The 
prognosis for cure of these patients even when they developed GTT was 
good. 
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INTRODUCTION 
Gestational trophoblastic disease IS a spectrum of 
heterogenous conditions which arise from products of conception 
and which may threatened the livehood and health of the young 
women. Although uncommon, its importance lies in the need for 
early recognition if the treatment is to be translated into cure and 
continued fertility. It is a health hazard which must be included 
in the differential diagnosis of a wide variety of clinical 
conditions. 
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CLASSIFICATION 
Because the spectrum is wide and heterogenous, there have been 
several attempts to classify GTD. These were handicapped by 
plethora of terms which have been applied to this disease and the 
diversify of diagnostic tool available. 
The World Healtb Organization (WHO) 1983 Classification 
Gestational Trophoblastic Disease 
Hydatidiform moles(HM) Gestational trophoblastic tumour (GTT) 
I 
Complete Moles Partial Mole Invasive mole 
Gestational Choriocarcinoma 
Placental site trophoblastic tumour 
FIGURE 1: CLASSIFICATION OF GTD (WH01983) 
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Gestational trophoblastic diseases (GTD) refer to both the 
benign and malignant permutations of proliferative trophoblastic 
allograft: Hydatidiform moles, invasive mole, choriocarcinoma, 
and placenta-site trophoblastic tumour (PSTT) 
Hydatidiform mole IS a general term that includes two 
distinct entities, complete Hydatidiform mole and partial moles. 
(i) Complete mole: is an abnormal conceptus without the embryo 
or fetus characterized by loss of villous vascularity leading to 
gross hydropic swelling and central cistern formation and to 
pronounced cytotrophoblastic and syncytiotrophoblastic 
hyperplasia. (ii) Partial mole: IS an abnormal conceptus with 
persistent embryonic and fetal elements and a placenta with a 
mosaic of normal -appearing villi alternating with areas of focal 
villous swelling and trophoblastic hyperplasia. 
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Invasive mole : IS a Hydatidiform mole that has invaded 
the myometrium, metastasized, or both. It often progresses but 
usually regressed spontaneously. 
Gestational Choriocarcinoma : is a malignant neoplasm 
of cytotrophoblastic and syncytiotrophoblastic elements 
without villous formation. It usually progresses and metastasizes 
and is fatal without treatment. 
Placental site trophoblastic tumour IS composed 
mainly of cytotrophoblastic intermediates cells arising from the 
placental implantation. 
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CELLULAR CLASSIFICATION 
Gestational trophoblastic tumors may be classified as 
follows: hydatidiform mole, chorioadenoma destruens (invasive 
mole), choriocarcinoma, and placental-site trophoblastic tumor. 
Hydatidiform mole is defined as products of conception that lack 
an intact fetus and show gross cyst-like swellings of the 
chorionic villi due to accumulation of fluid. There IS 
disintegration and loss of blood vessels in the villous core. 
Invasive mole (chorioadenoma destruens) is a locally invasive, 
rarely metastatic lesion characterized microscopically by 
trophoblastic invasion of the myometrium with identifiable 
villous structures. Microscopically, this lesion is characterized by 
hyperplasia of cytotrophoblastic and syncytial elements and 
persistence of villous structures. 
Choriocarcinoma is a malignant tumor of the trophoblastic 
epithelium. Uterine muscle and blood vessels are invaded with 
areas of hemorrhage and necrosIs. Columns and sheets of 
trophoblastic tissue invade normal tissues and spread to distant 
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sites, the most common of which are lungs, brain, liver, pelvis, 
vagina, spleen, intestines, and kidney. 
Placental-site trophoblastic disease is an extremely rare 
tumor arising from the placental implantation site and resembles 
an exaggerated form of syncytial endometritis. Trophoblastic 
cells infiltrate the myometrium, and there is vascular invasion. 
Human placental lactogen is present in the tumor cells, while 
immunoperoxidase staining for ReG is positive in only scattered 
cells, and serum ReG is relatively low 
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GENERAL COMPARISON BETWEEN NORMAL PREGNANCY & GTD 
Table 1: Comparison Between Normal Pregnancy And GTD 
D NORMAL ITRANsmoNAll PARTIAL I COMPLETE GESTATION. MOLE _ MOLE. MOLE 
If Itvilli with fetal I Some swelling. Focal IAU villi swollen ~essels. Most nonnal Villi swelling of and empty (no 
I
lHistology I with nonnaI villi without vessels). 
vessels. vessels. 
r ~~ara:d I 
ntam I 
~essels. ~ 
I Single layer of \HYPOPlasia of Focal Circumferential All atypical overgrowth ~ 
cytotrophoblast [CYl0trophoblast syncytial . atypical of cytotrophoblast and 
~d Ed-J r ·r lasm pvergrowth of ~cytiotrophoblast 
syncytiotrophOblastJ~tiotropboblast ~sealloping). pYiotTophoblast 
II ~ ~.:otr' _u [ 
~ beG SO-l00,OOO 
<50,000 >SO,OOO usually I 
hCG Low I HCG HCG I hCG>50!,OOO ~ 
_ ~75%) 1~~==4ro=-C~I~~=1=xy======~~:=:=:=~=~====~C~~~~7~O~id~Y~:~~~:o~9=5~%====~~==========~~,. 
I 2:1 IT II 
I n ~ 
$mall for I Small for "1 Baby 
Weight 
!Appropriate. for 
[Gestaional Ag~ 
II 
~ Gestational 
~e85% I ~estationa1 I Gesational Age ~ 65% ~3% 
I 
Data from Kate 0 Hanlan MD Gynaecology Oncology ,Surgey, endoscopy 
http://www.ohanian.comltneoplasia.htm 
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INCIDENCES 
Table 2: Examples of Hydatidiform mole incidence by region 
(WHO 1983) 
Country Period of study Rate Qer 1000 Pregnancies Deliveries Live-births 
Population Based Study 
Latin America Paraguay 1960-1969 0.2 
North America Canada 1969-1973 0.7 
Greenland 1950-1974 1.2 
USA 1970-1977 1.1 
Asia Japan 1974-1980 1.96 
Singapore 1963-1965 1.2 
Europe Norway 1953-1961 0.8 
Hospital based Study 
Afiica Nigeria 1969-1973 5.8 
Nigeria 1974-1977 2.6 
Nigeria 1966-1975 1.7 
Uganda 1967-1970 1.0 
Latin America Jamaica 1953-1967 1.0 
Mexico 1961-1965 4.6 
Venezuela 1939-1968 0.9 1.1 l.1 
North America USA 1930-1965 0.7 
Alaska 1969-1974 3.9 
USA 1932-1942 0.5 
Hawaii 1951-1965 0.8 
Hawaii 1950-1970 1.0 
Asia China 1951-1960 8.0 
Indonesia 1962-1963 10.0 11.6 
Iraq 1960-1964 4.5 
Iran 1964-1965 7.8 10.6 
Iran 1970-1975 3.2 
Israel 1950-1965 0.8 
Japan 1972-1977 1.9 2.6 
Lebanon 1956-1960 2.6 
Malaysia 1972-1976 1.5 
Philippines 1955-1957 1.1 
Thailand 1966-1972 2.8 2.9 
Europe Italy 1961-1974 0.8 
Oceania Australia 1940-1959 2.4 
Australia 1950-1966 0.9 1.0 
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Hydatidiform Moles per 1000 Pregnancies 
2' 3 4 5 6 7 8 9 
• I . I 
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~--------------------J PhilippInes 1 :200 t-----------------------..J Mexico 1:200 ~-----------------..J Iraq 1:221 t-----------_-------J United Siaies (Hawaii) t :238 
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~~lUI:oc.Ir;.&.iILII~~ Japan 1 :522 )-______ --' Hong Kong t :530 
)-____ - ...... Mulco 1:613 
Australia , :820 ~"'~1'7':1"1111 Singapore 1 :823 
~r.&oI~ .. "" United Slales 1 :923 
1--___ .,1 Uganoa t :970 
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United States (Los Angeles) 1: 1115 
..... _ ... ,; Bellast 1:1190 
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illllfMIM Israe' 1:1300 
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United States (New York) 1:1349 
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United Slales (New York, 1 :1700 
United Slates (Cook Counly) 1 :1724 
'--l 
10 11 12 
lndonesa. 1:85 
PREGNANCY IMMUNOLOGY 
The uterus is not an immunologically privileged site. Fetal tissue, 
as well as trophoblastic neoplasia, does demonstrate antigenic 
immaturity with respect to ABO and HLA. There is, importantly, 
a nonantigenic barrier formed by the syncytotrophoblastic cells 
which produce a mucoprotein layer of sialomucin, which is 
protective. Furthermore, maternal immunoglobulins recognizing 
any foreign antigens will attach to this basement membrane and 
function as "blocking antibodies" covering the antigens. Despite 
this, due to significant normal vascular invasion by the 
trophoblast, some of the epithelial cells of the villi will "deport", 
and travel through the venous return through the heart, imbedding 
in the lung parenchyma. 
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GENETIC BACKGROUND 
Hydatidiform can be catogerized as either complete mole or 
partial mole on the basis of karyotype , gross morphology, and 
histolpathology as table below: Palmer JR (1994) 
Table 3: General Comparison between Complete & 
Partial Mole 
I 
Characteristic 
II 
Complete Mole 
II 
I 
Karyotype 46, XX (900/0) 
I 
46, XV (100/0) 
I 
Fetal Tissue Absent 
II 
I 
Hydatidiform swelling 
I 
Extensive 
II 
Trophoblastic hyperplasia 
I 
Extensive 
II 
Data from Kate 0 Hanlan MD Gynaecology Oncology ,Surgey, endoscopy 
http://www.ohanlan.com/tneoplasia.htm 
Partial Mole 
Triploid(900/0 ) 
Present 
Limited 
Limited 
Complete moles lack identifiable embryonic or fetal tissue, the 
chorionic villi exhibit generalized hydropic swelling and diffuse 
trophoblastic hyperplasia , and implantation site trophoblast has 
diffuse and marked atypia. 
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I 
I 
I 
I 
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GROWTH FACTORS & ONCOGENES 
The excess of paternal chromosomes in moles probably 
contributes to the induction of trophoblastic hyperplasia . The 
genomic imbalance may cause changes in the gene expression of 
growth factors located on the paternal allele (Berkowitz RS, et al 
1985). An insul in growth factors (IGF2 ) specifically located on 
the paternal allele may be inappropriately expressed in molar 
pregnancies, thus stimulating uncontrolled growth. 
Both normal placentas and molar pregnancies contain 
paternal antigens; therefore, upon implantation, an immunologic 
response IS initiated with infiltration of lymphocytes and 
macrophages and secretion of cytokines. The growth of 
choriocarcinoma may be related to the abundant expression of 
epidermal growth factor receptor. Macrophage derived cytokines 
interleukin (IL-l alpha, 11-1 beta), and tumour necrosis factor can 
suppress cell growth and increase EGF receptor expression in 
choriocarcinoma cell lines, thus acting as paracrine mediators of 
cell growth. 
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The contribution of several oncogenes to the malignant 
transformation of GTD also has been examined. Growth 
regulation in the trophoblast recently has been found to be 
associated with expression of the transciption factor Mash-2. 
Cheung et al (1993) have demonstrated increase expression of c-
fm RNA in complete mole compare with that in normal placenta. 
In choriocarcinoma, increase expression of c-myc and ras RNA 
has been observed. At present, the significance of these findings 
is uncertain. Because trophoblast are, by nature, rapidly dividing 
and invasive, increase expression of these oncogenes may be 
essential for normal cell function. Further studies are needed to 
el ucidate these findings. Recently, expression of the c-erb B-2 
oncogene product in persistent GTD was examined and found to 
have a significant contribution. Thus far, no gene mutation or 
rearrangement in GTD have been reported. 
Progression of the tumour has been associated with the 
inactivation of tumour suppressor gene. The inactivation of p53 
by mutation of the p53 gene has been observed in nearly 50% of 
patient with ovarian cancer. Expression of p53 in hydatidiform 
moles has recently been studied. Expression of p53 In 
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hydatidiform mole was observed to be increased over that normal 
trophoblast. No p53 mutation were found and further noted an 
over accumulation of p53 protein in 50% choriocarcinoma and 
78% of hydatidiform moles but none in partial mole and normal 
placenta. Increase p53 expression may thus be an attempt to 
abrogate excessive trophoblast proliferation in hydatidiform 
moles. 
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Table 3.1: Clinicopathological Characteristic Of The Various 
Classes Of Molar Pregnancy 
Features Complete mole Partial Mole Transitional Mole 
Synonym Classic; True Incomplete Blighted Ovum 
Villi Pronounced s\velling Crinkled hydropic Cystic, hydropic and 
of all villi villi are focal ., normal 
I 
haphazard : many 
villi nonnal 
Trophoblast Cyto and syncytial Mostly syncytial No hyperplasia, may 
hyperplasia is hyperplasia; focal I be hypoplasia 
variable and mild 
r 
Embryo Dies very early: No Usually dies by 9 Amnion and slunted 
remnant found . weeks ; may survive embryo 
I 
till tenn 
Villous I No fetal Red blood Many fetal red blood Present 
capillaries cell cell 
Gestational 8-16 weeks usual 10-22 weeks 16-14 weeks 
Age 
BeG values >50,000 miulml 75o/(} <50,OOOmilliml Lo\v 
Malignant I. 15-25% 5-10% Slight, if any 
Potential 
Karyotype 46)0(95%) Triploid (80%) Trisomic, triploid 
46, XY (10~!o) 
Data from Szuiman and Surti 1984 
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STAGE INFORMATION 
Hydatidiform mole (molar pregnancy) is disease limited to 
the uterine cavity. Invasive mole (chorioadenoma destruens) is a 
locally invasive, rarely metastatic lesion. 
The FIGO staging system is os follows: 
Stage I: Disease confined to the uterus 
Stage IA: Disease confined to the uterus with no risk factors 
Stage m: Disease confined to the uterus with one risk factor 
Stage IC: Disease confined to the uterus with two risk factors 
Stage II: GTT extends outside of the uterus but is 
limited to the genital structures (ovary, tube, vagina, 
broad ligament) 
Stage llA: GTT involving genitaJ structures without risk factors 
Stage DB:GTT extends outside of the uterus but limited to genital structures with one 
risk factor 
Stage nC:GTT extends outside of the uterus but limited to the genital structures with two 
risk factors 
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Stage ill: GTT extends to the lungs, with or without 
known genital tract involvement 
Stage IDA: GTI extends to the lungs, with or without genital tract involvement and with 
no risk factors 
Stage D1B: GTI extends to the lungs, with or without genital tract involvement and with 
one risk factor 
Stage me: GIT extends to the lungs, with or without genital tract involvement and with 
two risk factors 
Stage IV: All other metastatic sites 
Stage IVA: All other metastatic sites, without risk factors 
Stage IVB: All other metastatic sites, with one risk factor 
Stage IVe: All other metastatic sites, with two risk factors 
Table 4: Staging and survival rate of GTT 
!Staging of Gestational Trophoblastic Tumour 
I II II 5 - Years Survival 
IStage 0 IIHydatidiform mole 11100% 
ftage I 
I Persistent Hydatidiform 
1100% mole 
ftage " I Met~stases to pelvis or ro -100% vagina 
IStage III IIMetastases to lung 111000/0 
Istage IV 
I Metastases to liver, brain, ~o -80% etc. 
Data from Kate 0 Hanlan MD Gynaecology Oncology ,Surgey, endoscopy 
http://www.ohanlan.comltneoplasia.htm 
GESTATIONAL TROPHOBLASTIC DISEASE 1995-1999 HTAA KUANTAN 17 
I 
I 
I 
I 
I 
I 
I 
HUMAN CHORIONIC 
GONADOTROPIN ASSAY 
Successs in the treatment of GTD has been achieved In 
part because of the technical ability to quantitate serum or 
urInary concentrations of human chorionic go.nadotrophin 
(heG). Regular monitoring of beG concentrations during 
treatment provides information regarding disease status and the 
response to therapy that permits appropriate intervention on an 
individualized basis. The hCG assay thus has become essential 
to the clinical management of trophoblastic disease, and basic 
understanding of the assay methods and their limitations is the 
important for the clinician involved in the care of these patients. 
It has recently been recognized that heG IS present in 
patients in multiple forms: intact heG, nicked hCG where the 
binding site of the tumour has been split, heG which has lost the 
carboxy terminal part of the beta subunit, free beta and beta core 
fragment. Early in a normal pregnancy the majority of heG is in 
intact form and nicking occurs increasingly through the 
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pregnancy. In GTT there is a much higher proportion of heG 
degradation products present and not all pregnancy test detect 
these efficiently. The ideal heG test for monitoring GTT is one 
which detects all the beta epitopes present in intact heG through 
the beta core fragment. (Cole et al 1994). 
Human chorionic gonadotrophin (hCG ) is a sensitive and 
specific marker for the diagnosis and treatment of gestational 
trophoblastic tumour. Bagshawe (1976) defined the risk more 
specifically, noting the fatality rate of 4 % if the beG was less 
than 10,000 IU, 150/0 at 10,000 - 100,000 IU, 27 % at 100,000-
1,000,000 IU and 61 'Yo when the level was greater than 
1,000,000 IU. Lurain et al (1982) reported that heG level 
greater than 100,000 IU IL were significantly associated with 
fewer remission in patients with metatastatic GTT. 
The usefulness of the HeG subunit assays in the prediction 
of the development of malignant disease has not been settled. 
Recent reports suggest that secretion of free b-hCG subunit in 
comparison to whole HeG secretion showed an increasing trend 
from pregnancy to mole to choriocarcinoma, and the free b-hCG 
subunit level may be used in the prediction of GTD (Patiilo & 
Houssa 1984, Khazaeli 1986, Fan 1987). Free b-hCg subunit 
secretion appeared to be related to the maturity or degree of 
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differentiation of the trophoblast. Nigerian pregnant women 
were found to secrete a persistently higher percentage of alfa -
hCG free subunit when compared with American pregnant 
women (Elegbe 1984). During the IVth World Congress of 
Gestational Trophoblastic Disease held in Beijing in October 
1988, preliminary results of b-hCG core fragment estimation 
reported that this may be useful for the early diagnosis of 
malignant disease during the follow up of mole patients. Ma 
H.K. et al (1990). 
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Normal postmolar pregnancy curve for serum b-bCG 
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FIGURE 3: NORMAL POST MOLAR PREGNANCY CURVE 
FOR SERUM B-hCG RIA. VERTICAL BARS INDICATE THE 
95% CONFIDENCE LIMIT (Morrow et al 1998) 
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Abnormal Regression of serum beG 
Brewer et al (1971), Bagshawe et al (1973) provide a basis 
for the interpretation of post molar gonadotrophin val ues 
relative to the diagnosis of GTT and the need of therapeutic 
intervention. Brewer et al (1971) reported that by 60 days after 
molar evacuation, approximately 70% of their patients achieved 
a normal heG level, that is, less than 25miu/ml. An additional 
15% demonstrates continuous drop in their values, although the 
values were still higher than normal. In the remaining 15% of 
the group with an elevated heG at 60 days after evacuation, the 
values were either plateu or rising. 
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COMPLETE HYDATIDIFORM MOLE 
This entity is characterized by the absence of a fetus and a 
uterus filled by grossly swollen avascular villi made up of 
oedematous stroma surrounded by hyperplastic 
syncyctiotrophoblast. The incidence~ which IS difficult to 
determine and varies geographically, is approximately I per 
1000 live births. Genetically it is usually diploid. 
Symptomatology 
Patients with Hydatidiform mole present as a complication 
of an existing pregnancy and a positive pregnancy test. The 
presenting symptoms can be bleeding, passage of grapes like 
product or hyperemesis gravidarum (30%). Pain is not a 
dominant symptom. 
Clinical sign. 
These patients are usually well with no overt distress or 
haemodynamic comprise but they may be pale. If hyperemesis is 
present, they may be signs of dehydration and ketosis. 
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In 65% of patients, uterine examination will reveal a fundal 
height discordant with gestational age. The consistency of the 
uterus is doughy rather than cystic. 
Vaginal examination may confirm bleeding or a dilated cerVIX 
with vesicles products of conception in the vagina. 
Twenty percent of patients will show features of pre-eclampsia. 
Proteinuric hypertension before 20 weeks of pregnancy should 
raise the possibility of GTD. Hyperthyroidism may manifest as· 
clinical thyrotoxicosisin 10% of cases. 
Diagnosis and investigation 
The ultrasound appearance of an enlarged uterus with 
echolucent black hole surrounded by a rim of white is absolutely 
specific. Abdominal x ray may provide useful information (an 
absent fetal skeleton) and excessive opacification in the region 
of the uterine shadow. But if ultrasonography not available, 
patients with suspected molar disease, if at all possible, should 
be referred to an institution with this facility. Pelvic 
angiography and amniography are specific but excessively 
invasive. Extensive investigation for metastatic disease is not 
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